UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Hepatology (Baltimore, Md.), ISSN 0270-9139, 01/2017, Volume 65, Issue 1, pp. 18 - 31
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Antibody-Dependent Cell Cytotoxicity | Lymphocyte Activation | Humans | Middle Aged | Male | Monocytes - immunology | Killer Cells, Natural - physiology | Lipopolysaccharide Receptors | Galectins - physiology | Hepatitis C, Chronic - immunology | Aged, 80 and over | Adult | Female | Aged | Alanine | Liver | Chronic infection | Cytotoxicity | Leukocytes (mononuclear) | Infections | T cell receptors | Lymphocytes T | Hepatoma | CD14 antigen | Galectin-9 | Hepatitis | Monocytes | Cell activation | Clonal deletion | Hepatocytes | Persistent infection | Alanine transaminase | Peripheral blood mononuclear cells | Natural killer cells | Hepatitis C | Phosphatidylserine | Apoptosis | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2014, Volume 123, Issue 12, pp. 1957 - 1960
Life Sciences & Biomedicine | Hematology | Science & Technology | Cell Line | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pyrimidines - administration & dosage | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Rituximab | Pyrazoles - administration & dosage | Animals | Drug Interactions | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell - immunology | Pyrimidines - adverse effects | Cell Line, Tumor | Killer Cells, Natural - immunology | Killer Cells, Natural - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Killer Cells, Natural - metabolism | Antibody-Dependent Cell Cytotoxicity - drug effects | Lymphoma, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Pyrazoles - adverse effects | Index Medicus | Abridged Index Medicus | 12 | Correspondence | 39
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2015, Volume 6, pp. 368 - 368
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2008, Volume 14, Issue 14, pp. 4650 - 4657
monoclonal anitbodies | antibody-dependent cellular cytotoxicity | lenalidomide | natural killer cell | non-Hodgkin's lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Antibodies, Monoclonal, Murine-Derived | Antibodies, Monoclonal - pharmacology | Humans | Rituximab | Monocytes - immunology | Antigens, CD20 - metabolism | Thalidomide - pharmacology | Blotting, Western | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Monocytes - drug effects | Thalidomide - analogs & derivatives | Flow Cytometry | Hematologic Neoplasms - drug therapy | Killer Cells, Natural - immunology | Killer Cells, Natural - drug effects | Hematologic Neoplasms - immunology | Antibody-Dependent Cell Cytotoxicity - drug effects | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2010, Volume 125, Issue 6, pp. 1344 - 1353.e2
Allergy and Immunology | antibody-dependent cell-mediated cytotoxicity | IL-5 | FcγRIIIα | basophil | eosinophil | monoclonal antibody | Asthma | IL-5 receptor | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Recombinant Fusion Proteins - immunology | Surface Plasmon Resonance | Epitope Mapping | Eosinophils - metabolism | Epitopes - metabolism | Eosinophils - drug effects | Interleukin-5 Receptor alpha Subunit - immunology | Cell Count | Humans | Antibodies, Monoclonal - adverse effects | Macaca fascicularis | Interleukin-5 Receptor alpha Subunit - metabolism | Male | Recombinant Fusion Proteins - metabolism | Receptors, IgG - metabolism | Protein Engineering | Female | Eosinophils - pathology | Mutagenesis, Site-Directed | Antibody-Dependent Cell Cytotoxicity | Interleukin-5 Receptor alpha Subunit - genetics | Antibody Affinity | Animals | Antibodies, Monoclonal - administration & dosage | Recombinant Fusion Proteins - genetics | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | gamma RIII alpha | Lungmedicin och allergi | Respiratory Medicine and Allergy
Journal Article
6.
Full Text
Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
Immunology and cell biology, ISSN 0818-9641, 04/2017, Volume 95, Issue 4, pp. 347 - 355
Immunology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Macrophages - physiology | Killer Cells, Natural - transplantation | Immunotherapy, Adoptive - methods | Antibody-Dependent Cell Cytotoxicity | Cytokines - metabolism | Receptors, Antigen, T-Cell, gamma-delta - metabolism | Antigens, Neoplasm - immunology | Humans | Antibody Affinity | Molecular Targeted Therapy | Receptors, IgG - metabolism | Neoplasms - therapy | Animals | Neoplasms - immunology | Killer Cells, Natural - immunology | T-Lymphocytes - immunology | Toll-Like Receptors - metabolism | Index Medicus
Journal Article
Journal of immunological methods, ISSN 0022-1759, 05/2014, Volume 407, pp. 63 - 75
Glycosylation | Monoclonal antibody | Afucosylated antibody | CD16a | ADCC assay | Antibody-dependent cell-mediated cytotoxicity | Biochemistry & Molecular Biology | Immunology | Life Sciences & Biomedicine | Biochemical Research Methods | Science & Technology | Cell Line | Immunotherapy, Adoptive - methods | Reproducibility of Results | Antibodies, Monoclonal, Humanized - therapeutic use | Antibody-Dependent Cell Cytotoxicity | Humans | Transgenes - genetics | Immunoglobulin G - therapeutic use | Immunoglobulin Allotypes - immunology | Receptors, IgG - metabolism | Immunoglobulin G - immunology | Leukocytes, Mononuclear - immunology | Killer Cells, Natural - immunology | Cytotoxicity Tests, Immunologic - methods | Antibodies, Monoclonal, Humanized - immunology | Health aspects | Immunoglobulin G | Biopharmaceutics | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 22, pp. 4393 - 4402
COMPLEMENT | RITUXIMAB | IN-VIVO | LIPID RAFTS | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | MONOCLONAL-ANTIBODY | FOLLICULAR LYMPHOMA | C-RECEPTOR POLYMORPHISMS | UMCG Approved | FULLY HUMAN | Life Sciences & Biomedicine | Hematology | Science & Technology | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Animal tumors. Experimental tumors | Experimental tumors, general aspects | Antineoplastic agents | Tumors | Lymphoma, Non-Hodgkin - immunology | Neoplasm Transplantation | Humans | Lymphoma, B-Cell - therapy | Macaca fascicularis | Transplantation, Heterologous | Antibodies, Monoclonal, Humanized | Lymphoma, B-Cell - immunology | Protein Engineering | Female | Antibodies, Monoclonal - immunology | Antigens, CD20 - immunology | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity | Antibodies, Monoclonal - pharmacology | Rituximab | Receptors, IgG - immunology | Mice, SCID | Antibodies, Monoclonal - genetics | Animals | B-Lymphocytes - immunology | Lymphoma, Non-Hodgkin - therapy | Cell Line, Tumor | Immunoglobulin Variable Region - genetics | Mice | In Vitro Techniques | Immunity, Cellular | Immunoglobulin Fc Fragments - genetics | Lymphocyte Depletion - methods | Cytotoxicity, Immunologic | Index Medicus | Abridged Index Medicus | Immunobiology
Journal Article
Cancer immunology research, ISSN 2326-6066, 10/2015, Volume 3, Issue 10, pp. 1148 - 1157
Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Leukocytes, Mononuclear - metabolism | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Interferon-gamma - metabolism | Biomarkers, Tumor | Receptors, IgG - genetics | Neoplasms - genetics | Leukocytes, Mononuclear - immunology | Killer Cells, Natural - immunology | Antineoplastic Agents - pharmacology | Cell Membrane - metabolism | Interleukin-12 - pharmacology | T-Lymphocytes, Cytotoxic - immunology | Gene Expression | Antibody-Dependent Cell Cytotoxicity - genetics | Leukocytes, Mononuclear - drug effects | Antibodies, Monoclonal - pharmacology | Genotype | B7-H1 Antigen - genetics | B7-H1 Antigen - metabolism | B7-H1 Antigen - antagonists & inhibitors | T-Lymphocytes, Cytotoxic - metabolism | Neoplasms - immunology | Cell Line, Tumor | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Antibody-Dependent Cell Cytotoxicity - drug effects | Interferon-gamma - pharmacology | Index Medicus | anti-PD-L1 | antibody-dependent cellular cytotoxicity | checkpoint inhibitor
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 3, pp. 399 - 409
immunomodulation | mantle cell lymphoma | antibody‐dependent cell‐mediated cytotoxicity | lenalidomide | natural killer cell | antibody-dependent cell-mediated cytotoxicity | Life Sciences & Biomedicine | Hematology | Science & Technology | Pyrazoles - therapeutic use | Coculture Techniques | Humans | Tumor Microenvironment | Thalidomide - pharmacology | Dose-Response Relationship, Drug | Thalidomide - analogs & derivatives | Killer Cells, Natural - immunology | Tumor Cells, Cultured | Cytotoxicity, Immunologic - drug effects | Lymphoma, Mantle-Cell - genetics | Lymphoma, Mantle-Cell - metabolism | Peptide Hydrolases - metabolism | Pyrazoles - pharmacology | Lenalidomide | Pyrimidines - administration & dosage | Immunologic Factors - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Pyrimidines - pharmacology | Thalidomide - administration & dosage | Ubiquitin-Protein Ligases | Adaptor Proteins, Signal Transducing | Pyrazoles - administration & dosage | Pyrimidines - therapeutic use | Lymphoma, Mantle-Cell - immunology | Lymphocyte Count | Killer Cells, Natural - drug effects | Mutation | Thalidomide - therapeutic use | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Viral antibodies | Tyrosine | Killer cells | Gene mutations | Analysis | Antibodies | Lymphomas | Immunomodulation | Toxicity | Cytotoxicity | Immunological synapses | Kinases | Survival | Patients | Lymphoma | Granzyme B | Immunology | Lymphocytes | Mantle cell lymphoma | Natural killer cells | Mantle | Protein-tyrosine kinase | Tumors | Index Medicus
Journal Article